Related Experiment Video
Updated: Jan 19, 2026
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Published on: October 3, 2025
[Prevalence of metabolic health in Mallorca obese patients]
Jorge Blanco Anesto1, María Del Mar Bibiloni1, Josep Antoni Tur Marí1
1Grupo de Investigación en Nutrición Comunitaria y Estrés Oxidativo. Universidad de las Islas Baleares y CIBEROBN.
Introduction:
Aims: to assess the prevalence of metabolic health in Mallorca obese patients. Methods: participants were classified in metabolically healthy obese (MHO) and metabolically non-healthy obese (MNHO). Food, toxic and lifestyle habits, time of obesity evolution, breastfeeding, obesity in childhood and family history of obesity and diabetes mellitus, as well as glycemia, total cholesterol, HDL-cholesterol and triglyceridemia were evaluated in 457 obese patients. Results: prevalence of MHO was 49.2% and that of MNHO was 50.8%. MHO phenotype decreased with age. All patients showed inadequate habits. Consumption of fruits, salads and vegetables, tobacco and physical activity were similar between both groups; 37.4% of patients consumed sugary sweet drinks, and 52.9% consumed alcohol, higher in MNHO (4.3%) than in MHO (0.4%). MNHO showed higher values of BMI, abdominal circumference, fat percentage and visceral fatty index, as well as all metabolically studied outcomes. Conclusions: more than half of assessed obese population showed metabolic complications, but all obese population showed similar inadequate food and lifestyle habits. Increase of age, low educational level, years of obesity evolution, and visceral localization of fat are associated with a metabolically non-healthy status. Criteria to define and typify the metabolic state of obese subjects should be unified.
More Related Videos
05:10Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
05:10Multidisciplinary Approach to Obesity Management: A Case Report
Drug Dosing: Obese Patients
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution